MSC Site Disclaimer
- Details
- Category: MSC Site Info
- Written by R. Adam Quigley
- Hits: 1810
MSChristian strives to make the information on the MSC Web site as timely and accurate as possible, MSC makes no claims, promises, or guarantees about the accuracy, completeness, or adequacy of the contents of this site, and expressly disclaims liability for errors and omissions in the contents of this site. No warranty of any kind, implied, expressed, or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, fitness for a particular purpose or freedom from computer virus, is given with respect to the contents of the MSC Web site or its links to other Internet resources.
The information appearing on this Web site is for general informational purposes only and is not intended to provide legal and or medical advice to any individual or entity. We urge you to consult with your own legal and or medical adviser before taking any action based on information appearing on this site or any site to which it may be linked.
Links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by MSChristian of any of the products, services or opinions expressed by any corporation, organization or individual. MSChristian bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content. When you select a link to an outside Web site, you are subject to the privacy, copyright, security, and information quality policies of that Web site.
Reference in this site to any specific commercial product, process, or service, or the use of any trade, firm or corporation name is for the information and convenience of the public, and does not constitute endorsement, recommendation, or favoring by MSC.
MSChristian welcomes comments and suggestions from the World Wide Web community. However, anything contradicting the stated policies and objectives will not be responded to or used by this web site. You may visit www.mschristian.org for more information and use the contact us form for any correspondence.
Is MS fatal?
- Details
- Category: Frequently Asked Questions
- Written by R. Adam Quigley
- Hits: 2048
No, MS does not have a significant impact on life expectancy.
What causes MS?
- Details
- Category: Frequently Asked Questions
- Written by R. Adam Quigley
- Hits: 1917
The cause of MS is still unknown, although there is a lot of speculation and research. MS could be the result of a common virus. Genetics may also be a factor, although MS is not directly inherited.
Who can get MS?
- Details
- Category: Frequently Asked Questions
- Written by R. Adam Quigley
- Hits: 1539
MS is usually diagnosed between the ages of 20 and 40. Although anyone can get it, some people are more susceptible than others. Women are 2-3 times more likely to develop MS than men. Additionally, caucasions and those who live in high latitudes are more likely to develop MS.
What is Multiple Sclerosis?
- Details
- Category: Frequently Asked Questions
- Written by R. Adam Quigley
- Hits: 1645
Multiple Sclerosis, or MS, is an autoimmune disease of the central nervous system in which the protective covering around nerves is destroyed, disrupting the communication between the brain and nerve pathways.
Quick Facts
- Details
- Category: Frequently Asked Questions
- Written by R. Adam Quigley
- Hits: 1250
|
Why do people get MS?
- Details
- Category: Treatment and Diagnosis of MS
- Written by R. Adam Quigley
- Hits: 1437
The best simple answer is "bad luck." A more complete explanation is that why an individual develops MS is due to a combination of factors which elevated risk. In the US, about 1 in 250 people will develop MS. Most of the risk of getting MS has to do with ancestry. Having a close relative with MS elevates the risk 50 times. However, only 2-5% of children of affected parents will be diagnosed with MS. People of Northern European descent, and those who grow up farther from the equator, are more at risk. However, any person can get MS. The risk to African Americans is about ½ of that of Caucasians in the US. Despite this, most people with MS do not have an affected family member. Some families break these rules and have many affected members, but the usual situation is that MS is less of a genetic illness than diabetes, heart disease, Parkinson’s disease, or Alzheimer’s disease.
MS in some respects appears to be a consequence of an infectious disease. Numerous investigations have failed to yield a consistent relationship with a single infectious agent. However, everyone with MS has a virus known as EB. EB is a very common virus which affects almost 90% of people, and infects their immune system in a lifelong fashion. It causes mononucleosis, also known as mono.
Most specialists who treat MS believe it occurs uncommonly at random following an infection with a common virus, leading to a disorder of the immune response which injuries the brain unnecessarily.
Sanofi SA risks falling behind in the battle for share of the fast-growing multi-billion euro multiple sclerosis (MS) market, as rivals push ahead with revolutionary treatments while doubts remain over the French drugmaker's own drug candidates.
MediciNova Inc, a biopharmaceutical company, has received a Notice of Allowance from the US Patent and Trademark Office for a pending patent application, which covers the use of ibudilast for the treatment of progressive forms of multiple sclerosis. 
Complex clinical trial designs and manufacturing steps required for biosimilars treating multiple sclerosis (MS) in Europe will likely stave off market entry for at least several years, drug consultants told Biopharm Insight. 
